Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,497.7
-3.1 (-0.12%)

 

  • STI Straits Times Index
    2,497.7
    -3.1 (-0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,506.6
    -6.4 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,455.4
    114.6 (0.47%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,338.1
    67.7 (2.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,360.3
    40.9 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,059.2
    20.8 (0.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,595.1M
  • Value: 1,877.8M
  • Rise: 152
  • Fall: 154
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.157-0.008
Oceanus^0.007-
Frasers L&C Tr1.420+0.010
NetLink NBN Tr0.965-0.010
Jiutian Chemical0.045-
Alset0.063+0.002
Rex Intl0.156+0.003
HPH Trust USD0.132+0.007
Golden Agri-Res0.141-0.001
Medtecs Intl1.070-0.110

World Indices

World Indices
Name Last Change
Nasdaq 10,793.3 -117.0
HSI 24,455.4 +114.6
HSCEI 9,803.1 +71.0
Jakarta 5,059.2 +20.8
Nikkei 225 23,360.3 +40.9
SSE Comp 3,338.1 +67.7
Shanghai A 3,498.5 +71.0
Shanghai B 251.8 +1.7
KOSPI 2,412.4 +6.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NOVARTIS AG SPONSORED ADR
Updated on 18 Sep 2020 (End of trading day)
Last (USD): 90.940 Change: -0.030 High: 91.860 Remarks: -
Change (%): -0.03 Low: 90.300
Open 91.860 Yesterday's Close 90.97
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,275,866 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 2.85694 Trailing EPS (USD) e 2.92581 NAV (USD) b 21.8121
PE a 31.831 Trailing PE f 31.082 Price / NAV b 4.1692
Dividend (USD) d 1.842434 Cash In Hand (USD) g 2.3984 Issued & Paid-up Shares c 2,467,060,000
Dividend Yield (%) d 2.026 Price / Cash In Hand g 37.917 Treasury Shares h 239,453,391
Market Cap (M) 224,354.436 Enterprise Value (M) 252,920.348
Piotroski F Score 5 Exchange Code NVS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 27.07 Free Float (%) -
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 18 Sep 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 224,354.436 31.831 31.082 4.1692 2.026
Industry Pharmaceuticals: Major NYSE 119,997.277 25.088 26.104 5.3427 1.896
Local Peer JOHNSON & JOHNSON NYSE 392,764.088 25.978 25.865 6.2365 2.513
Local Peer MERCK & CO INC NYSE 217,034.084 22.050 20.711 7.8516 2.644
Local Peer PFIZER INC NYSE 203,548.514 12.509 14.365 3.1638 3.969
Local Peer ABBVIE INC NYSE 159,028.831 20.279 23.041 10.8125 4.083
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 148,157.541 110.522 68.824 12.1072 2.427
Local Peer ELI LILLY AND COMPANY NYSE 147,458.980 31.794 26.247 36.0278 1.675
Local Peer BRISTOL-MYERS SQUIBB CO NYSE 133,590.431 38.846 - 2.7211 2.802
Local Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 125,864.166 21.555 20.521 13.9080 1.638
Local Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 98,490.777 16.621 15.405 5.8641 4.968
Local Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 58,988.514 144.971 59.693 1.3579 -
Local Peer BIOHAVEN PHARMACEUTICAL HLDG CO LTD NYSE 3,790.690 - - -106.8832 -
Local Peer ADC THERAPEUTICS SA NYSE 3,217.573 - - 28.9459 -
Other Local Peers ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), LANNETT CO INC (NYSE)
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 132,037.103 40.581 10.750 1.8571 2.229
Global Peer WUXI APPTEC HKEx 257,912.218 122.862 92.988 12.7023 0.231
Global Peer HANSOH PHARMA HKEx 228,177.065 78.706 82.919 11.8335 -
Global Peer ROYALTY PHARMA PLC NASDAQ 25,486.310 10.852 10.852 6.1307 -
Global Peer INNOVENT BIO HKEx 87,693.084 - - 12.4975 -
Global Peer CUREVAC NV NASDAQ 9,270.353 - - -193.4993 -
Global Peer CANSINOBIO-B HKEx 60,096.105 - - 39.8318 -
Global Peer REPLIGEN CORP NASDAQ 7,664.855 357.985 247.741 6.9679 -
Global Peer SINOPHARM HKEx 57,882.281 8.166 8.456 1.0166 3.363
Global Peer JUNSHI BIO HKEx 45,349.968 - - 17.3425 -
Other Global Peers SH PHARMA (HKEx), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), HYGEIA HEALTH (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), BAIYUNSHAN PH (HKEx), ALLAKOS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), HENLIUS-B (HKEx), CHINARES PHARMA (HKEx), PRINCIPIA BIOPHARMA INC (NASDAQ), CHINAGRANDPHARM (HKEx), AKESO-B (HKEx), CMS (HKEx), HEPALINK (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), TRAD CHI MED (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), UNITED LAB (HKEx), INNOCARE-B (HKEx), OCUMENSION-B (HKEx), FORMA THERAPEUTICS HLDGS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), SSY GROUP (HKEx), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CKLIFE SCIENCES (HKEx), Kimia Farma Tbk. (IDX), CSTONE PHARMA-B (HKEx), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), Soho Global Health Tbk. (IDX), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), TONGRENTANGCM (HKEx), KRYSTAL BIOTECH INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), IMMUNOTECH-B (HKEx), TCR2 THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), HUA MEDICINE-B (HKEx), APREA THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), TRICIDA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), IGBB (Bursa), KALA PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SHINEWAY PHARM (HKEx), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), STARPHARMA HOLDINGS LIMITED (ASX), BEYONDSPRING INC (NASDAQ), FUSEN PHARM (HKEx), IMARA INC (NASDAQ), 89BIO INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), IMMUNIC INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), DURECT CORP (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), AMAG PHARMACEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), BSTEAD (Bursa), UROVANT SCIENCES LTD (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), TOT BIOPHARM-B (HKEx), XERIS PHARMACEUTICALS INC (NASDAQ), PHARMA (Bursa), CYCLERION THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), ESSA PHARMA INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), VERU INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ZHONGZHIPHARM (HKEx), AVENUE THERAPEUTICS INC (NASDAQ), DAWNRAYS PHARMA (HKEx), ETON PHARMACEUTICALS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), SOL GEL TECHNOLOGIES LTD (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), CH BIOTECH SER (HKEx), HARROW HEALTH INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), BIOMX INC (NYSE American), EVOLUS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), KOTRA (Bursa), IX Biopharma (SGX), PROTARA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), MEDIWOUND LTD (NASDAQ), Merck Tbk. (IDX), NEW RAY MEDIC (HKEx), Hyphens Pharma (SGX), Phapros Tbk. (IDX), EYENOVIA INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), NEP INTERLONG (HKEx), ONCOSIL MEDICAL LIMITED (ASX), IP (SET), ASSERTIO HOLDINGS INC (NASDAQ), PAK FAH YEOW (HKEx), EYEPOINT PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 10 ORD SHS (R/S) (NASDAQ), NOVAN INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), NOVA (Bursa), RACE ONCOLOGY LTD (ASX), EDESA BIOTECH INC (NASDAQ), BIOHLDG (Bursa), PALLA PHARMA LTD (ASX), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CHARMACY PHAR (HKEx), NC HEALTHCARE (HKEx), NOXOPHARM LTD (ASX), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), PAINREFORM LTD (NASDAQ), WAI YUEN TONG (HKEx), IMMURON LIMITED (ASX), PROPHASE LABS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TBG DIAGNOSTICS LTD (ASX), ONCTERNAL THERAPEUTICS INC (NASDAQ), INVION LTD (ASX), PURAPHARM (HKEx), ANNOVIS BIO INC (NYSE American), MANNATECH INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), SANAI HEALTH GP (HKEx), AGEX THERAPEUTICS INC (NYSE American), JCT (SET), DARE BIOSCIENCE INC (NASDAQ), EXTRAWELL PHAR (HKEx), HOTH THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), SUN BIOPHARMA INC (NASDAQ), EXOPHARM LTD (ASX), SPRING BANK PHARMACEUTICALS INC (NASDAQ), PHARMAXIS (ASX), BRICKELL BIOTECH INC (NASDAQ), ENTERA BIO LTD (NASDAQ), SUNZEN (Bursa), ACRUX (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), FIJI KAVA LTD (ASX), ADIAL PHARMACEUTICALS INC (NASDAQ), SINOLIFE UTD (HKEx), NOVUS THERAPEUTICS INC (NASDAQ), PASHUN INT'L (HKEx), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TALI DIGITAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), SUDA PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), CELLMID LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), TELIGENT INC NEW (NASDAQ), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.060
+1.18 %
10 Days -+4.260
+4.91 %
20 Days -+4.540
+5.25 %
Medium Term Return 3 Months --0.160
-0.18 %
6 Months -+18.520
+25.57 %
1 Year -+3.870
+4.44 %
Long Term Return 2 Years 2.834+15.914
+24.99 %
3 Years 5.771+15.299
+27.86 %
5 Years 8.488+10.778
+24.03 %
Annualised Return Annualised --
+4.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 69.180 - 99.843 Change From 1 Year Low +21.760 % Change From 1 Year Low (%) +31.45
Change From 1 Year High -8.903 % Change From 1 Year High (%) -8.92
2 Years Range 69.180 - 99.843 Change From 2 Years Low +21.760 % Change From 2 Years Low (%) +31.45
Change From 2 Years High -8.903 % Change From 2 Years High (%) -8.92
5 Years Range 58.758 - 99.843 Change From 5 Years Low +32.181 % Change From 5 Years Low (%) +54.77
Change From 5 Years High -8.903 % Change From 5 Years High (%) -8.92
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Sep 2020 91.860 91.860 90.300 90.940 2,275,866 -
17 Sep 2020 90.240 90.990 89.890 90.970 2,154,133 -
16 Sep 2020 92.270 92.270 89.680 89.850 5,933,053 -
15 Sep 2020 91.730 91.970 90.870 91.000 1,049,775 -
14 Sep 2020 89.580 90.521 89.550 90.030 1,172,618 -
11 Sep 2020 90.420 90.680 89.340 89.880 1,860,432 -
10 Sep 2020 89.720 89.870 88.370 88.520 1,655,451 -
09 Sep 2020 88.400 89.120 88.220 88.220 1,360,549 -
08 Sep 2020 86.900 87.900 86.470 87.330 1,635,669 -
04 Sep 2020 87.300 87.480 85.440 86.680 1,526,557 -
03 Sep 2020 89.230 89.230 86.560 87.100 1,840,811 -
02 Sep 2020 87.800 88.950 87.740 88.860 1,638,565 -
01 Sep 2020 87.890 87.890 86.210 86.870 2,986,050 -
31 Aug 2020 86.380 86.950 86.040 86.060 2,320,436 -
28 Aug 2020 86.620 86.680 85.840 86.600 1,436,178 -
27 Aug 2020 88.150 88.228 86.670 87.000 1,372,123 -
26 Aug 2020 86.430 87.060 86.310 87.030 1,358,641 -
25 Aug 2020 86.910 86.934 86.130 86.450 1,431,163 -
24 Aug 2020 86.750 86.990 86.030 86.380 919,882 -
21 Aug 2020 86.230 86.470 85.860 86.400 896,693 -
20 Aug 2020 85.960 87.320 85.750 87.140 1,992,008 -
19 Aug 2020 86.510 86.600 85.300 85.470 1,676,019 -
Summary
Current 2 Weeks
(04 Sep 2020 to 18 Sep 2020)
87.300 92.270 85.440 90.940 20,624,103 -
Previous 2 Weeks
(21 Aug 2020 to 03 Sep 2020)
86.230 92.270 85.440 87.100 16,200,542 -
4 Weeks from
(24 Jul 2020 to 20 Aug 2020)
84.770 92.270 83.805 87.140 34,975,134 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.